Table 5.
Author, Year, [Ref.] | Patient’s Features | Type AIP | IBD | Treatment at AIP Recurrence | Anti TNF Therapy |
---|---|---|---|---|---|
Lorenzo D et al., 2020 [93] | Woman, 28 years old | AIP type 2 | Negative for IBD | Rituximab | Adalimumab |
Lorenzo D et al., 2020 [93] | Woman, 16 years old | AIP type 2 | Ulcerative colitis | / | Adalimumab |
Lorenzo D et al., 2020 [93] | Woman, 38 years old | AIP type 2 | Crohn disease | Azathioprine and then methotrexate | Infliximab |
Lorenzo D et al., 2020 [93] | Woman, 18 years old | AIP type 2 | Crohn disease | Azathioprine | Adalimumab |
Naghibi M et al., 2013 [94] | Woman, 16 years old | AIP type 1 | IgG4 positive colitis | Azathioprine and then infliximab | Adalimumab |
AIP: autoimmune pancreatitis; IBD: Inflammatory Bowel Disease; Anti TNF: anti Anti-Tumor Necrosis Factor; IgG4: Immunoglobulin G4.